99 results on '"Looijenga, Leendert H.J."'
Search Results
2. Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
3. Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
4. Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
5. Germ Cell Tumors, Pathology, and Genetics
6. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
7. Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
8. Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review
9. Managing the Risk of Germ Cell Tumourigenesis in Disorders of Sex Development Patients
10. Advances in Molecular Markers of Germ Cell Cancer in Patients with Disorders of Sex Development
11. P-28 The potential of MET immunoreactivity for prediction of lymph node metastasis in early tongue squamous cell carcinoma
12. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
13. Evaluation of an Algorithm for Testis-Sparing Surgery in Boys with Testicular Tumors: A Retrospective Cohort Study
14. Mediastinal germ cell tumors: many questions and perhaps an answer
15. Testis Sparing Surgery in Pediatric Testicular Tumors
16. A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding, and loss of E-cadherin with poor prognosis in oral squamous cell carcinoma
17. Abstract A53: Hypermethylated RASSF1A as circulating tumor marker in pediatric and adolescent solid tumors
18. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers
19. MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions
20. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis
21. Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
22. Meiotic arrest occurs most frequently at metaphase and is often incomplete in azoospermic men
23. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas
24. Cell-free MicroRNA miR-505-3p in Graft Preservation Fluid Is an Independent Predictor of Delayed Graft Function After Kidney Transplantation
25. The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
26. Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
27. Molecular Heterogeneity and Early Metastatic Clone Selection in Testicular Germ Cell Cancer Development
28. c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
29. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor
30. Improved Progression Prediction in Barrett’s Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria
31. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
32. Management of Gonads in Adults with Androgen Insensitivity: An International Survey
33. Histological Assessment of Gonads in DSD: Relevance for Clinical Management
34. Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
35. Multiparameter Investigation of a 46,XX/46,XY Tetragametic Chimeric Phenotypical Male Patient with Bilateral Scrotal Ovotestes and Ovulatory Activity
36. DOC1-Dependent Recruitment of NURD Reveals Antagonism with SWI/SNF during Epithelial-Mesenchymal Transition in Oral Cancer Cells
37. VASA mRNA (DDX4) detection is more specific than immunohistochemistry using poly- or monoclonal antibodies for germ cells in the male urogenital tract
38. NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development
39. A Rare Case of Embryonal Carcinoma in a Patient with Turner Syndrome without Y Chromosomal Material but Mutations in KIT, AKT1, and ZNF358 Demonstrated Using Exome Sequencing
40. The biology of germ cell tumors in disorders of sex development
41. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance
42. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors
43. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
44. MET expression during prostate cancer progression
45. Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia
46. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma
47. Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors
48. Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution
49. Gonadal Maldevelopment as Risk Factor for Germ Cell Cancer: Towards a Clinical Decision Model
50. An oncofetal and developmental perspective on testicular germ cell cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.